The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 354:1424-1426 March 30, 2006 Number 13
NextNext

Infliximab for Ulcerative Colitis

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
 by Rutgeerts, P.
-PubMed Citation
To the Editor: As Rutgeerts et al. mention in their article about infliximab for ulcerative colitis (Dec. 8 issue),1 nocturnal fecal incontinence in patients who have an ileoanal pouch is, indeed, an "inconvenience" that is reminiscent of their presurgery symptoms of colitis (but without the debilitating disease). However, Hahnloser et al. do not state the overall prevalence as 24 percent.2 Their data actually show that the proportion of patients with more than two episodes of nocturnal staining per week was 5 percent. The proportion increased to 24 percent only after 15 years, by which time the population had aged to . . . [Full Text of this Article]




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.